Autoimmune hepatitis and multiple sclerosis: a coincidental association?

Area of Science:

• Neuroimmunology
• Hepatology
• Autoimmune Diseases

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Autoimmune hepatitis (AIH) is a liver inflammation of autoimmune origin.
• The co-occurrence of MS and AIH is rare, but potentially significant.

Purpose of the Study:

• To investigate the prevalence of autoimmune hepatitis (AIH) within a large cohort of multiple sclerosis (MS) patients.
• To assess the potential association between MS and the development of AIH.
• To provide recommendations for the clinical management of MS patients with elevated liver enzymes.

Main Methods:

• Retrospective analysis of a large multiple sclerosis (MS) patient cohort (n=1800).
• Identification of patients diagnosed with autoimmune hepatitis (AIH).
• Comparison of AIH prevalence in the MS cohort versus the general population.

Main Results:

• Three cases of untreated multiple sclerosis (MS) patients developed autoimmune hepatitis (AIH).
• The prevalence of AIH in the MS cohort was observed to be 0.17%, significantly higher than the general population prevalence of approximately 0.0169%.
• This suggests a potentially increased risk of AIH in individuals with MS.

Conclusions:

• A higher prevalence of autoimmune hepatitis (AIH) may exist in multiple sclerosis (MS) patients.
• Systematic liver biopsy is recommended for untreated MS patients presenting with persistently elevated liver enzymes.
• Further research is warranted to elucidate the underlying mechanisms connecting MS and AIH.